Accessibility
Animation
Accessibility
This white paper discusses the future path of pharmacovigilance from a safety, regulatory and technological perspective. It argues the need to rethink traditional Pharmacovigilance (PV) strategies and discusses the influential role technology including cloud-based solutions, mobile applications, robotic automation, artificial intelligence (AI) and big data analytics will play in transforming the safety continuum.